KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Tax Provisions: 2010-2025

Historic Tax Provisions for Novavax (NVAX) over the last 6 years, with Sep 2025 value amounting to -$657,000.

  • Novavax's Tax Provisions rose 36.34% to -$657,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 74.47%. This contributed to the annual value of $10.9 million for FY2024, which is 435.89% up from last year.
  • Novavax's Tax Provisions amounted to -$657,000 in Q3 2025, which was down 169.45% from $946,000 recorded in Q2 2025.
  • Over the past 5 years, Novavax's Tax Provisions peaked at $16.6 million during Q4 2021, and registered a low of -$2.3 million during Q4 2022.
  • In the last 3 years, Novavax's Tax Provisions had a median value of $1.2 million in 2023 and averaged $1.3 million.
  • Per our database at Business Quant, Novavax's Tax Provisions slumped by 128.20% in 2023 and then skyrocketed by 1,641.96% in 2024.
  • Novavax's Tax Provisions (Quarterly) stood at $16.6 million in 2021, then slumped by 113.61% to -$2.3 million in 2022, then soared by 174.69% to $1.7 million in 2023, then surged by 341.29% to $7.4 million in 2024, then soared by 36.34% to -$657,000 in 2025.
  • Its last three reported values are -$657,000 in Q3 2025, $946,000 for Q2 2025, and $1.2 million during Q1 2025.